Orally active factor Xa inhibitors: investigation of a novel series of 3-amidinophenylsulfonamide derivatives using an amidoxime prodrug strategy.
Uchida M, Okazaki K, Mukaiyama H, Isawa H, Kobayashi H, Shiohara H, Muranaka H, Kai Y, Kikuchi N, Takeuchi H, Yokoyama K, Tsuji E, Ozawa T, Hoyano Y, Koizumi T, Misawa K, Hara K, Nakano S, Murakami Y, Okuno H.
Uchida M, et al. Among authors: takeuchi h.
Bioorg Med Chem Lett. 2008 Aug 15;18(16):4682-7. doi: 10.1016/j.bmcl.2008.07.009. Epub 2008 Jul 9.
Bioorg Med Chem Lett. 2008.
PMID: 18667303